Trexall
NDC 51285-369, Methotrexate, tablet, film coated, from Teva Women's Health LLC.
- Product NDC
- 51285-369
- Status
- Listed
- Labeler
- Teva Women's Health LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040385
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51285-369 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM15 mg/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51285-369-01 | 51285036901 | 30 TABLET, FILM COATED in 1 BOTTLE (51285-369-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e942f8db-510f-44d6-acb5-b822196f5e8cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51285-369
Use it
Look up 51285-369 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51285-369 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51285-369. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.